Patient-oriented composite endpoint ( POCE , including all death , all myocardial infarction ( MI ) and all revascularisations ) , major adverse cardiac events ( MACE , including cardiac death , MI and clinically indicated target vessel revascularisation ) and stent thrombosis were assessed at 5-year follow-up .